Diadema Partners LP Eledon Pharmaceuticals, Inc. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 64,613 shares of ELDN stock, worth $181,562. This represents 0.06% of its overall portfolio holdings.
Number of Shares
64,613
Previous 75,794
14.75%
Holding current value
$181,562
Previous $312 Million
29.86%
% of portfolio
0.06%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
86Shares Held
37.1MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$17.7 Million0.94% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$10 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$8.3 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$6.54 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$6.48 Million2.06% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $38.7M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...